Optimizing myeloma treatment for frail patients: dosing, scheduling and administration

Clark DuMontier, MD, MPH, VA Boston Healthcare System, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, discusses dosing, scheduling, and the route of administration of multiple myeloma treatment in elderly and frail patients. His insights underscore the crucial balance between disease control and the preservation of quality of life (QoL). This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.